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A B S T R A C T
Fracture ﬁxation devices are implanted into a growing number of patients each year. This may be
attributed to an increase in the popularity of operative fracture care and the development of ever more
sophisticated implants, which may be used in even the most difﬁcult clinical cases. Furthermore, as the
general population ages, fragility fractures become more frequent. With the increase in number of
surgical interventions, the absolute number of complications of these surgical treatments will inevitably
rise. Implant-related infection and compromised fracture healing remain the most challenging and
prevalent complications in operative fracture care. Any strategy that can help to reduce these
complications will not only lead to a faster and more complete resumption of activities, but will also help
to reduce the socio-economic impact. In this review we describe the inﬂuence of implant design and
material choice on complication rates in trauma patients. Furthermore, we discuss the importance of
local delivery systems, such as implant coatings and bone cement, and how these systems may have an
impact on the prevalence, prevention and treatment outcome of these complications.
 2016 Elsevier Ltd. All rights reserved.
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The most challenging musculoskeletal complications in trauma
surgery are implant-related infection and compromised fracture
healing [1–5]. These complications may result in permanent
functional loss or even amputation in otherwise healthy patients
[6]. Furthermore, the reported socio-economic effect is signiﬁcant.
Darouiche published that in cases of implant-related infection, the
costs per patient could be as high as 15,000 USD [3]. Hak et al.
stated that the direct treatment cost of an established nonunion
was 11,000 USD [5]. In a study by Chung et al., amputation was
compared to limb salvage in grade IIIb and IIIc open tibia fractures.
The reported lifetime cost, in complicated cases that underwent
amputation, could be up to 680,000 USD [7].
Accurately estimating the impact of fracture related complica-
tions has been hampered by the lack of clear deﬁnitions for these
complications: for example, there is a lack of consensus regarding
the deﬁnition of compromised fracture healing, for which there are
no available standard criteria [1]. ‘Compromised fracture healing’
and ‘nonunion’ are general terms for healing disturbances, and are
used interchangeably in this text.
In this review, we describe the latest research aimed at
understanding the factors that may lead to implant-related
infection, fracture healing complications, and the development
of strategies to prevent and treat them. In particular, we describe
the contribution of implant properties and local delivery systems
on complications in fracture care. Data will be drawn from
preclinical experimental research as well as translational and
clinical studies to illustrate the current research directions in this
ﬁeld.
Implant choice and design
Plate design and outcome
The inﬂuence of the implant on the outcome in fracture care has
been described in different publications over the past decades
[8–12]. Over time, different plate concepts or designs have been
created, from the dynamic compression plate (DCP), the limited
contact DCP (LC-DCP) (Fig. 1), through to point contact ﬁxator (PC-
Fix) and more recently the locking compression plate (LCP)
[8]. These devices have been developed to improve fracture
healing, reduce soft tissue and vascular damage but it also has been
found that these devices have a different susceptibility to infection
[8,13]. Experimental studies demonstrated that implant designs
that reduce the area of necrosis in and near the area of contact with
the bone have reduced infection rates [14]. This is believed to be
due to the fact that infection spreads along a contiguous area ofFig. 1. Dynamic compression plate (DCP; top) and limited contact dynamic
compression plate (LC-DCP; bottom). In the LC-DCP design the area of plate-
bone contact (footprint) is greatly reduced thus improving cortical perfusion.
Images reproduced with kind permission of the Copyright by AO Foundation,
Switzerland [12].
Please cite this article in press as: Metsemakers W-J, et al. Inﬂuence o
operative fracture care. Injury (2016), http://dx.doi.org/10.1016/j.injnecrosis [14]. The goal of biological internal ﬁxation is to minimise
and isolate bone-implant contact, whilst at the same time allow
adherence or integration with adjacent tissue to avoid a ﬂuid-ﬁlled
dead space.
The DCP provides ﬁxation by compression of bone fragments
across the fracture gap and also compression between the plate
and the underlying bone across a large footprint [6]. The large area
of compression results in compression induced restriction of blood
ﬂow to the periosteum and in the bone, leading to tissue necrosis
[8]. The more recently developed, so-called locked internal ﬁxators
(e.g. PC-Fix and Less Invasive Stabilization System (LISS)), consist of
plate and screw systems where the screws are locked in the plate,
which reduces the area of contact between the plate and bone
minimising, the damage caused to the periosteum (Fig. 2) [8,15].
The greater protection of the periosteum provided by the PC-
Fix, leading to greater viability of tissues, improved fracture
healing by reducing tissue necrosis, but also improved resistance
to infection in comparison with DCP implants by the same
mechanism [8]. Eijer et al. investigated, in a rabbit model, local
infection rates after fracture ﬁxation with plate osteosynthesis,
performed by different implantation techniques [14]. The overall
infection rate was higher for the DCP-group with surface contact
compared with the PC-Fix group with point contact. The
development of the LCP has only been possible based on the
experience gained with the PC-Fix [8,12,15]. The LCP with
combination holes can be applied, using a conventional technique
(compression principle), a bridging technique (internal ﬁxator
principle), or a combination technique (compression and bridging
principles), depending on the fracture type [12,15].
Nail design, reaming and outcome
IMN was already introduced by Ku¨ntscher in 1939 [16]. It is the
treatment of choice for shaft fractures of long bones. With respectFig. 2. The concept of the Less Invasive Stabilization System (LISS) comprises a
contoured plate to which the screws interlock. Stability comes from the angular
stability of the plate-screw interface and not from friction between plate and bone.
By this method the system minimises implant-to-bone contact and consequently
avoid vascular damage to the osseous blood supply.
f implant properties and local delivery systems on the outcome in
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is more likely to occur after IMN with hollow nails than with solid-
core nails. In a study by Horn et al., for example, the aim was to
determine if cannulated intramedullary nails had a lower
resistance to infection than solid nails. In rabbits, the intrame-
dullary cavity was inoculated with Staphylococcus aureus, and one
of the nails was inserted. The solid nail had a greater resistance to
infection compared to that of the cannulated nail [9]. Melcher et al.
published analogous results in two similar animal studies
[17,18]. An explanation for these results may be the fact that
there is less ‘dead-space’ in solid-core nails compared with
cannulated nails, whereby the dead space allows bioﬁlm formation
in the absence of vascularisation and associated host defences. In a
clinical study in human patients, Riemer et al. treated 29 patients
with tibial diaphyseal fractures with unreamed solid core nails for
nonunion after initial long-term stabilisation with external ﬁxators
[19]. Infection rates were low, although the authors reported
already a few local infections before placement of the nails. This is
remarkable, as we know that late conversion of external ﬁxation to
IMN increases the risk of infection as does the appearance of active
pin tract infections [20].
Although it is clear that nail design has an impact on the
outcome, the factor of reaming needs to be taken in to account as
well, especially because of the correlation between nail design and
the necessity to ream the fracture site (e.g. reamed (hollow) and
unreamed (solid) nails). Intramedullary reaming allows shaping of
the medullary canal facilitating the insertion of larger diameter
nails, which provides a more stable osteosynthesis [21]. A
described advantage of reaming would be that the debris is a
source of mesenchymal stem cells (MSC’s) and growth factors that
contribute to accelerated bone healing [22]. The MSC’s are derived
from bone marrow and trabecular bone fragments [22]. Although
this seems positive, not all long bones are suitable for reaming.
Most studies advise for example the use of unreamed nails in the
humerus, as reaming can cause iatrogenic fractures and uncon-
trolled fragment movement putting the adjacent radial nerve at
risk [23]. Other side effects associated with intramedullary
reaming are partial destruction of the medullary blood supply
[24], as well as generation of high pressure and an increase in
temperature within the medullary cavity [25,26]. With respect to
femoral shaft fractures, concerns have risen regarding the local and
systemic effects of reaming. The procedure leads to elevated
intramedullary pressure and systemic embolisation of bone
marrow contents [21]. Consequently intramedullary instrumenta-
tion results in stimulation of the inﬂammatory system [27]. These
systemic disturbances could contribute to pulmonary morbidity,
due to acute respiratory distress syndrome (ARDS), in patients with
multiple injuries [28]. A study performed by the Canadian
Orthopaedic Trauma Society however, found that there was no
difference in the incidence of ARDS between patients receiving
reamed and unreamed IMN [29].
Regarding compromised fracture healing, the inﬂuence of
reaming on the outcome of long bone fracture treatment is still a
subject of debate [30]. Comparative studies between reamed and
unreamed nailing in femoral shaft fractures give conﬂicting results
on healing outcome [31–35]. A recent large prospective trial gave
more insight on treatment outcomes of tibial shaft fractures
[36]. The authors stated that reaming resulted in a better outcome
in closed fractures compared to open fractures. More speciﬁcally,
open fractures as a whole were associated with statistically
equivalent reoperation rates, but there was a trend toward better
healing in those receiving unreamed IMN. This was conﬁrmed by
Metsemakers et al. in a recently published large retrospective
study [37].
The correlation between reaming and infection has also been an
issue of debate over the past decades. In an experimental study byPlease cite this article in press as: Metsemakers W-J, et al. Inﬂuence o
operative fracture care. Injury (2016), http://dx.doi.org/10.1016/j.injMelcher et al. the same solid steel nail was inserted either with
prior reaming of the medullary cavity or without reaming in rabbit
tibia [17]. All rabbit tibia were inoculated with S. aureus. Lower
infection rates were observed in the unreamed group versus the
reamed group, although the difference was small (50% versus 64%
infection rate). An explanation for these results is that in complex
open fracture cases with extensive periosteal stripping, the
external blood supply through the periosteum has been compro-
mised. The bone now depends on its medullary supply, which will
be destroyed by the reaming procedure. Indeed Schemitsch et al.
showed, in a sheep model, that reaming essentially interrupts
cortical perfusion. This was reversible within 8–12 weeks, however
the limited blood supply prevents antibiotics from reaching the
fracture site and, in combination with a higher bacterial load in
open fractures, could theoretically also lead to higher infection
rates [38].
Clearly, there remain many questions regarding the impact of
implant choice and reaming on the outcome in fracture care today.
Further experimental and clinical studies are required to provide
an understanding of the fundamentals of these issues.
Titanium versus stainless steel
Uncoated metal implants, usually stainless steel, titanium or
titanium alloys (titanium–6% aluminium–7% niobium (TAN)) are
the most commonly used materials used in fracture care today
[39]. All these materials offer acceptable mechanical properties
and biocompatibility, however there are certain differences.
Titanium and its alloys have a lower modulus of elasticity
compared to other metals like stainless steel. Consequently, this
allows for increased ﬂexibility, which means that the elastic
deformations on titanium implants are a closer reﬂection to that of
bone [40].
Besides elasticity, the surface oxides of both materials are
different [39]. They differ in chemistry, thickness and their ability
to regenerate, which affects metal ion release from the surface.
Titanium and its alloys form a much thicker naturally occurring
oxide layer compared with stainless steel. When the oxide ﬁlm is
mechanically abraded (from any metal), this allows for the release
of metal ions from the highly reactive and less biocompatible bulk
material. This undesirable release of potentially toxic metal ions
continues until the oxide layer can be regenerated [39]. In general
the most toxic components (cobalt, chromium, nickel and iron) are
found in and released from stainless steel [41]. The toxicity of these
elements has been observed to negatively impact the vascular,
reproductive, excretory, sensory and respiratory systems [39].
In association with stainless-steel-based and cobalt-based
materials, contact hypersensitivity reactions have been described
and were mostly attributed to chromium, cobalt, nickel, and
occasionally to molybdenum [42]. In contrast, due to its excellent
biocompatibility, titanium is not considered to provoke allergic
reactions. However, in view of the few reports on contact
dermatitis or granulomatous reactions to titanium upon its use
in pacemakers or implants [43–45], the discussion about ‘titanium
allergy’ is still ongoing.
Furthermore, stainless steel produces more imaging artefacts
compared with titanium owing to its composition, which increases
its magnetic susceptibility [39]. The pure titanium implants are not
ferromagnetic and do not cause harm to patients in magnetic
resonance imaging (MRI) units [39,40].
Finally, when comparing stainless steel with titanium it must
be recognised that steel is usually electropolished (EPSS) to a
smooth surface, whereas titanium in its standard form has a
microrough surface. Therefore, when comparing steel with
titanium there is not only a material difference but also a
topographical difference. These mentioned surface differencesf implant properties and local delivery systems on the outcome in
ury.2016.01.019
Fig. 3. Histological appearance of the surface of plates (black) in contact with bone, 12 weeks after implantation in a rabbit non-fracture model. The image on the left shows an
EPSS plate in contact with the bone (dark purple). Note the soft-tissue capsule between plate and bone. The right image shows a rough stainless steel plate. Note the bone
growth towards the plate (pink), in combination with bony attachment onto the plate. For permanent implants, this direct bone bonding is advantageous as it supports
implant stability (copyright by AO Foundation, Switzerland) [12].
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tissue adhesions. EPSS is void of micro discontinuities, this
generally supports ﬁbrous–osseous integration upon implantation
(Fig. 3) [12,39,46]. The standard microrough surface of titanium
supports direct osseointegration [12,39,46], which is also true for
rough steel (Fig. 3). This shows that EPSS and titanium have
different biocompatibility characteristics.
Improved adhesion of tissue to microrough titanium over EPSS
could be the reason for the reduced prevalence of capsule
formation around titanium implants in comparison with EPSS
implants (Fig. 4) [12,39,47]. In a rabbit model, Ungersbock et al.
also found a ﬂuid ﬁlm between the EPSS implants and the adjacent
tissue layer [48]. A ﬁbrous capsule surrounding a liquid-ﬁlled void
at the tissue-implant interface, creating a dead-space, without
vascularisation, favours the development of infection [49,50]. The
interior of the capsule is avascular and thus isolated from its
surroundings [48]. This means that microorganisms are protected
from outside aggressors such as macrophages and antibiotics.
Earlier experimental data (in vitro and in vivo) indeed indicated
that titanium is superior to EPSS regarding infection susceptibility
[17,51,52]. However, these studies have some potential cofounders
making it difﬁcult to draw conclusions or to translate data to the
clinical situation. One of the cofounders is the use of different types
of plates. As already mentioned earlier, when comparing the
results of PC-Fix/LCP studies to DCP studies, it must be considered
that the DCP acts by compressing the plate onto the bone over a
large contact area resulting in damage to the periosteal vasculature
with resulting necrosis and by itself higher infection rates [8,14]. A
more recent study by Hudetz et al. compared titanium and EPSS in
a ‘subcutaneous’ mouse model. The authors stated that the metalFig. 4. Histological appearance of the surface of plates (black) in contact with soft-tissue
shows an EPSS plate with formation of a ﬁbrous capsule and a dead space or void ﬁlled wi
no liquid ﬁlled void present. After an initial nonspeciﬁc reaction, little inﬂammation an
Please cite this article in press as: Metsemakers W-J, et al. Inﬂuence o
operative fracture care. Injury (2016), http://dx.doi.org/10.1016/j.injplayed a minor role in susceptibility to and persistence of
staphylococcal infections [76].
Although it seems that direct osseointegration as occurs with
the microrough surface of titanium is positive, it also leads to
excessive tissue adhesions which complicates implant removal
and impairs limb function, for example with tendon adhesion after
ﬁxation of distal radius fractures [46,47,53,54]. Polishing of
titanium and its alloys is currently being investigated as a
potential approach for improving this outcome. Prior to clinical
implementation, the effect of polishing the surface of these devices
on infection rates needs to be ascertained, since polishing the
surface of commonly used metals can not only alter the
biocompatibility of the implant (with creation of a dead-space)
as mentioned earlier but also change bacterial adhesion in vitro
[50,52,55].
In an experimental study, Moriarty et al. investigated infection
rates of titanium, TAN and EPSS LCP implants in a non-fracture
rabbit model. No statistically signiﬁcant differences were found
between materials, even when the microtopography was changed
(polished) [49]. As we know that fracture biomechanics may
inﬂuence infection susceptibility, and the previous study used a
non-fracture model, further studies are required to deﬁnitively
determine the role of implant material and topography on
implant-related infections [2]. A suitable rabbit fracture model
has recently been described. Current work at the AO Research
Institute, Davos, Switzerland, focuses on testing infection suscep-
tibility of different metals in this biomechanically loaded model
(Fig. 5).
Only a few clinical studies compare titanium and EPSS. Holzach
et al. showed no differences in outcome after the treatment of, 12 weeks after implantation in a rabbit non-fracture model. The image on the left
th liquid (white) in between. The image on the right shows a titanium plate. There is
d no encapsulation are observed (copyright by AO Foundation, Switzerland) [12].
f implant properties and local delivery systems on the outcome in
ury.2016.01.019
Fig. 5. Contact radiograph of a rabbit fracture model. In this model an
osteosynthesis is performed using a 2.0 Locking Compression Plate (LCP) in
combination with 6 locking screws. At hole 4 an osteotomy is created with a Gigli
wire after which the plate is inoculated with Staphylococcus aureus. Images
reproduced with kind permission of the AO Research Institute Davos, Switzerland.
Fig. 6. Scanning electron microscope (SEM) image of in vitro bioﬁlm formation by
Staphylococcus aureus on a titanium disc. Images reproduced with kind permission
of the AO Research Institute, Davos, Switzerland.
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and titanium had the same good clinical outcome [56]. More
recently results from the SPRINT-trial were published [36]. The
investigators noted that when comparing EPSS intramedullary
nails to titanium nails for the treatment of tibial shaft fractures, the
EPSS nails had a higher risk of a negative event. Further evaluation
of their data revealed that this was mainly due to autodynamisa-
tion in the EPSS-group. This means that during weight bearing, the
EPSS locking screws fail, leading to dynamisation of the fracture.
The underlying biomechanical cause should be further studied in
the future. A study performed by Clauss et al. compared
percutaneous EPSS Kirschner wires with titanium Kirschner wires
used during toe deformity correction [57]. The conclusion of the
study was that titanium Kirschner wires had lower bacterial counts
and a superior clinical outcome compared to EPSS Kirschner wires.
Finally, a recent randomised controlled trial comparing the
stabilisation of closed femoral shaft fractures in children, showed
that both titanium and EPSS elastic nails were equally effective
treatment modalities, with similar rates of complications [58].
Despite the many differences between EPSS and titanium, both
materials provide a relatively predictable clinical outcome and
offer similar success for fulﬁlling the main requirements of fracture
ﬁxation [39,59].
Mixing metals in fracture care
Surgeons are hesitant to mix components made of different
metal classes for fear of galvanic corrosion. However, studies have
failed to show a signiﬁcant potential for galvanic corrosion
between titanium, stainless steel and cobalt chromium (CoCr).
In an early description in 1975, Ru¨edi already described that the
combination of titanium and stainless steel appears to be possible
and without danger in human patients [60]. More recently, an in
vitro study by Høl et al. showed that the combination of titanium
and stainless steel screws and plates did not cause higher weight
loss of the components or metal release than the single-material
constructions, indicating comparable clinical safety [61]. Interest-
ingly enough, in an in vitro study, Serhan et al. noted that when
using spinal implants the galvanic corrosion is less pronounced in
stainless steel-titanium mixed interfaces than in pure stainless
steel constructs [84]. Wa¨chter et al. performed a short-term in vivo
study. A mandibular defect in sheep was bridged using a titanium
plate in combination with titanium or stainless steel screws
[62]. In this study the combination of dissimilar screws and plates
did not cause a higher weight loss or metal release than the single-
material constructions, indicating comparable clinical safety. In an
in vivo model in sheep, Devine et al. conﬁrmed these statements
using CoCr guide wires in combination with stainless steel
cannulated screws [63].
In a clinical setting, it has already been proven in a study by
Acevedo et al. that mixing implants with different metallicPlease cite this article in press as: Metsemakers W-J, et al. Inﬂuence o
operative fracture care. Injury (2016), http://dx.doi.org/10.1016/j.injcompositions on the same bone, for the treatment of upper-
extremity fractures, does not increase the existence of corrosion or
complications [64]. It has to be stated that in this study the
titanium and stainless steel implants were in close proximity to
each other, without actual direct contact.
We conclude that although the mixture of titanium with
stainless steel is stated as ‘off label use’, there is no evidence from
large clinical trials showing the direct relationship with a negative
outcome [65].
Local delivery systems in fracture care
Introduction of systemic antibiotics
A large randomised clinical trial in the Netherlands, including
2195 patients, revealed that adequate single-dose antibiotic
prophylaxis substantially reduces the incidence of implant-related
infection after surgery for closed fractures [66]. Although an
experimental study by Worlock et al. showed promising results, an
equivalent large randomised trial has never been conducted for
open fractures [67]. A Cochrane analysis, summarising different
smaller studies, stated that the prophylactic administration of
systemic antibiotics for open fractures was associated with an
absolute risk reduction of 60% in developing infections compared
with placebo [68]. Guidelines from the Surgical Infection Society
support this conclusion and stated that a short course of ﬁrst-
generation cephalosporins, begun as soon as possible after the
injury, signiﬁcantly lowers the risk of infection in open fractures,
when used in combination with prompt, fracture and wound
management [69]. This is now accepted as standard of care.
Local delivery of antibiotics
Implant-related infections are typically caused by bioﬁlm
forming bacteria [70,71]. In contrast to infections caused by
free-ﬂoating (planktonic) bacteria, these infections generally
persist despite susceptibility of the causative bacteria to anti-
microbials. Furthermore, host defences are unable to eradicate
these microorganisms, which are protected by a highly hydrated
extracellular (exopolysaccharid) matrix (Fig. 6).
Improved infection prophylaxis could be achieved by incorpo-
rating potent antimicrobials into local delivery systems that
protect both the implant surface from bioﬁlm formation, but also
the surrounding tissues.
Despite the use of systemic antibiotics, open fractures still have
higher infection rates compared to closed fractures, especially inf implant properties and local delivery systems on the outcome in
ury.2016.01.019
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that systemic antibiotics may not reach the tissue-implant
interface in high enough concentrations to eradicate bacteria
due to local vascular damage. Locally delivering antibiotics is seen
as an easy way to overcome this problem. A recently performed
meta-analysis on the additional beneﬁt of local antibiotic therapy
in open tibia fractures showed that the rate of infection was lower
for all Gustilo-Anderson grades of open tibia fractures when local
antibiotics were administered as adjunctive prophylactic therapy
[74]. Patients with higher grades of open fractures, for example
Gustilo grade III open injuries, obtained the greatest beneﬁt from
this treatment. Local delivery systems in this study ranged from
antibiotic-loaded polymethylmethacrylate (PMMA) beads to
antibiotic coated tibia nails [75,76]. Although antibiotic-loaded
PMMA beads have been shown to reduce acute and chronic
infections in the most severe fracture cases, the beads require
second surgery for removal, or, in case of the bead pouch
technique, delay wound closure signiﬁcantly. Moreover systematic
review of the available literature showed that no large prospective
study has thus far proven that antibiotic-loaded PMMA beads are
effective in treating implant-related infections (Fig. 7) [77].
There are more reasons why different authors question the use
of PMMA as local delivery system. In a study by van de Belt et al.,
the release proﬁles of six types of bone cements were investigated
in vitro [78]. The authors showed that the released antibiotic fell
below the detection limit after one week and that a total of only 4–
17% of the incorporated antibiotic (gentamicin) was ﬁnally
released. In a clinical study by Neut et al., the authors retrieved
gentamicin-loaded PMMA beads after revision surgery for
prosthetic joint infections [79]. Extensive culture procedures
indicated the presence of bacteria on gentamicin-loaded beads in
18 of the 20 patients involved. Nineteen of 28 bacterial strains
isolated were gentamicin resistant and cultures from three
patients yielded highly gentamicin-resistant sub-populations.
The authors stated that the use of gentamicin-loaded PMMA
beads may contribute to the occurrence of re-infection with
resistant variants. Concerns have therefore been raised over theFig. 7. Computed tomography (CT) image of gentamicin-loaded PMMA beads, used
in a case of chronic implant-related infection after plate osteosynthesis of a distal
humerus fracture. Note that there has been bone loss after resection of a large bone
sequester.
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of antibiotics at a sub-therapeutic level from local delivery vehicles
with suboptimal release proﬁles [80].
The application of antibiotics through an implant coating is a
relatively new development [81]. Antibiotic coated intramedullary
nails do not necessitate additional removal surgeries or delay
wound closure, furthermore the release proﬁles from coatings
seem superior to that of PMMA without longstanding release of
antibiotics at a sub-therapeutic level [82]. These coated implants
have already shown initial promising results. Lucke et al.
performed an experimental study to compare systemic antibiotics
with the administration of local antibiotics for the prevention of
osteomyelitis [83]. The medullary cavities of rat tibiae were
contaminated with S. aureus and titanium Kirschner wires were
implanted into the medullary canals. The implants were coated
with a layer of poly(D,L-lactide) (PDLLA) loaded with gentamicin.
The onset of infection was prevented in 80–90% of animals treated
with gentamicin-coated Kirschner wires, with and without
systemic prophylaxis. Fuchs et al. published a study including
29 patients treated with a gentamicin-coated tibia nail [76]. The
study population included patients with complex tibial fractures
and late revision cases. No implant-related infections occurred.
The only trauma related implant that has been available on the
European market was the PROtect1 tibia nail (DepuySynthes,
Johnson/Johnson company, Inc New Jersey, USA). It is coated with a
layer of poly(D,L-lactide) (PDLLA) impregnated with gentamicin.
The current antibiotics of choice for incorporation in local
delivery systems are aminoglycosides (e.g. gentamicin). Concerns
have been raised regarding the emergence of resistance against
aminoglycosides, particularly secondary to gentamicin used in
local delivery vehicles [84,85]. Recently, a study by Metsemakers
et al. investigated the efﬁcacy of a biodegradable Polymer-Lipid
Encapsulation MatriX (PLEX) loaded with the antibiotic doxycy-
cline as a local prophylactic strategy against implant-related
infection [82]. While the previously mentioned PDLLA coating on
the PROtect1 tibia nail (DepuySynthes, Johnson/Johnson com-
pany, Inc New Jersey, USA) releases 80% of the gentamicin in 48 h,
this coating shows a burst release of 25% the ﬁrst day followed by
a daily sustained release of 3% up to 28 days. An advantage of
using doxycycline is that its resistance amongst the most
commonly encountered microorganisms causing implant-relat-
ed infection, including methicillin-resistant S. aureus (MRSA), is
still very low [86]. Furthermore, doxycycline enters host cells
very efﬁciently and thus may target the population of intracel-
lular bacteria, which gentamicin is less able to reach. Intracellu-
lar persistence of staphylococci in tissue surrounding implants,
especially in large numbers within macrophages, is a well-
described phenomenon [87,88]. This lack of clearance is likely
due to impairment of the host immune response in the presence
of an implant, also known as ‘frustrated phagocytosis’ [89]. The
authors stated that the PLEX-coating loaded with doxycycline
protected against implant-related infection caused by doxycy-
cline-sensitive, methicillin-sensitive S. aureus in a non-fracture
rabbit model (Fig. 8). Even when rabbits were challenged with a
doxycycline-resistant, methicillin-resistant S. aureus (MRSA)
strain, the PLEX coating signiﬁcantly reduced the proportion of
culture-positive samples.
Such antibiotic coated implants seem a potential option for the
prevention and treatment of infection in trauma patients with
open fractures and in septic revision cases [90,91]. In the future,
the development of biodegradable products like thermo-respon-
sive hydrogels, loaded with antimicrobials, would give the
musculoskeletal trauma surgeon a choice during surgery regarding
the implant or surface (e.g. bone, soft-tissue, plate or intramedul-
lary nail) he would like to protect by local application of this
patient speciﬁc ‘gel-coating’ [92].f implant properties and local delivery systems on the outcome in
ury.2016.01.019
Fig. 8. Contact radiograph of a PLEX-doxycycline coated implant in a rabbit non-
fracture model. Images reproduced with kind permission of the AO Research
Institute, Davos, Switzerland.[82].
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The rise in antibiotic resistant bacteria is driving researchers to
new treatment options. Antimicrobial peptides (AMP’s) have been
recognised as promising candidates for the new generation of
antimicrobial surfaces [93,94]. AMP’s are evolutionarily conserved
molecules involved in the defence mechanisms of a wide range of
organisms [93]. Produced in bacteria, insects, plants and verte-
brates, different AMP’s protect against a broad array of infectious
agents [93]. They have been the focus of great interest in recent
years owing to a low propensity for developing bacterial
resistance, broad-spectrum activity, high efﬁcacy at very low
concentrations, target speciﬁcity, and synergistic action with
classical antibiotics [94]. Animal osteomyelitis models showed
that certain AMP’s reduced bone infection caused by antibiotic
resistant and non-resistant strains of bacteria [95,96]. Currently,
cost and toxicity concerns have rendered their use restricted
[97]. They often display unspeciﬁc toxicity to cells, derived from
their interactions with any bilayer membrane; thus their
devastating power requires modulation. In the future, AMP’s
require covalent modiﬁcations and/or novel formulations to
become less toxic, more bioavailable and useful in the biomedical
ﬁeld [98].
Local delivery of bone morphogenetic proteins
Bone healing is also a potential target for local delivery systems
in fracture care. A current topic of interest, not only in acute
fracture care but also for the treatment of nonunion, is the use of
bone morphogenetic proteins (BMP’s). They are members of the
transforming growth factor (TGF)-beta superfamily and are known
to be very potent osteoinductive growth factors [99].
Animal studies have shown the potential of BMP-2 in acute
fracture care [100,101]. A few clinical trials have been conducted toPlease cite this article in press as: Metsemakers W-J, et al. Inﬂuence o
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fractures treated with intramedullary ﬁxation. The results were
contradictory. The BESTT-trial showed that local application of
BMP-2, using an absorbable collagen sponge, was signiﬁcantly
superior to the standard of care in reducing the frequency of
secondary interventions, accelerating fracture healing, and reduc-
ing the infection rate [102]. The BESTT-ALL study-group again had
positive results and noted that BMP-2 in combination with
allograft is safe and as effective as traditional autogenous bone-
grafting for the treatment of tibial fractures associated with
extensive traumatic diaphyseal bone loss [103]. But a more recent
trial by Aro et al. could not repeat these ﬁndings [104]. The author
stated that BMP-2 did not accelerate fracture healing in open tibial
fractures. Moreover, there was a trend towards higher infection
rates in the BMP-2 group. Probably methodological differences lie
at the basis of these different outcomes [105].
There are some potential hazards to the local application using
carriers, like collagen sponges, impregnated with BMP’s in open or
closed fracture sites. Not only infection, but also ectopic bone
formation in non-target tissue like blood vessels and nerves could
become a problem [106]. Schmidmaier et al. stated that the use of
BMP-2 coated implants could overcome these clinical problems
[107]. In a rat model, the authors showed that the use of these
implants is feasible and accelerates fracture healing. More
recently, Strobel et al. published an in vitro study were they
investigated the sequential release of an antibiotic and growth
factors from coated implants [108]. The authors stated that the
local application of antibiotics in combination with timely
controlled growth factor delivery might be beneﬁcial for the
prevention of infections and stimulate bone healing at the same
time [108].
The treatment of nonunions often requires the use of
additional grafting material, in this setting autologous bone
remains the gold standard [109]. However, the considerable
donor site morbidity associated with this procedure, the
reduced availability of autologous bone graft and the reduced
biological activity of MSC in autograft as the donor ages,
represent relative limiting factors for its use [109,110]. In this
setting further research on fracture healing focused on growth
factors, like BMP’s. As described in the Diamond-concept by
Giannoudis et al., the application of these exogenous growth
factors can play an important role in the treatment of nonunions
[111]. The registration of BMP-7, also known as human
osteogenic protein-1 (OP-1), for tibia nonunions was largely
based upon one of the ﬁrst randomised clinical trials on BMP-7,
published in 2001 by Friedlaender et al. [112]. Following this
study, the role of BMP-7 in stimulating bone healing has been
evaluated extensively and its efﬁcacy has been assessed in the
treatment of different long bone fracture nonunions with
encouraging results [113–115]. Giannoudis et al. published a
retrospective analysis of 45 patients treated with both BMP-7
and autograft [116]. These patients underwent a mean of 2 prior
operations (range 1–7), and the nonunions were located in long
bones (7 humerus, 19 femur and 19 tibia). All nonunions healed
after a median of 5 months.
Future prospective randomised trials should evaluate the
deﬁnitive place of BMP’s in prevention and treatment of
compromised fracture healing.
Conclusions and future perspectives
Two of the major problems in musculoskeletal trauma surgery
today are compromised fracture healing and implant-related
infection [1,2]. As already published by previous authors, they are
difﬁcult to treat and have a high socio-economic impact [3–5]. All
strategies that help to reduce these complications, will not onlyf implant properties and local delivery systems on the outcome in
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ﬁnancial burden of overall healthcare costs.
Important is that the surgical approach, the ﬁxation device used
and further, the design of the chosen fracture ﬁxation device and
its application can inﬂuence the susceptibility to these musculo-
skeletal complications.
Both materials that are most often used in fracture care today,
EPSS and titanium, provide a relatively predictable clinical
outcome and offer similar success for fulﬁlling the main
requirements of fracture ﬁxation [39,59].
With respect to implant-related infections, research focuses on
bioﬁlm forming bacteria. Most antimicrobial agents have a limited
efﬁcacy against bioﬁlm infections; therefore novel preventive and
therapeutic options are needed [117]. Local delivery systems, like
implant coatings, could be an asset in this ﬁeld. Furthermore, the
increased prevalence of antibiotic-resistant bacteria, particularly
MRSA, has become a signiﬁcant global healthcare issue
[118,119]. For this reason future studies will focus on other
non-antibiotic substances such as AMP’s and silver [94,120].
Finally, measures that prevent complications are currently of
more interest as the cost burden on total health care expenditures
due to these negative events, will only increase [7].
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